Edition:
United States

TherapeuticsMD Inc (TXMD.OQ)

TXMD.OQ on NASDAQ Stock Exchange Global Select Market

6.83USD
4:00pm EDT
Change (% chg)

$0.13 (+1.94%)
Prev Close
$6.70
Open
$6.70
Day's High
$6.89
Day's Low
$6.61
Volume
401,926
Avg. Vol
673,688
52-wk High
$7.66
52-wk Low
$4.34

Select another date:

Wed, May 30 2018

Photo

TherapeuticsMD's therapy for menopause-related condition gets approval

Women's healthcare company TherapeuticsMD Inc won its first-ever U.S. approval on Wednesday with the drug regulator clearing its hormone therapy for a painful condition triggered by menopause after rejecting it a year earlier.

UPDATE 2-TherapeuticsMD's therapy for menopause-related condition gets approval

* Shares volatile; last down 2 pct (Adds analyst, CEO comment, share movement)

FDA approves TherapeuticsMD's hormone therapy

May 30 The U.S. Food and Drug Administration approved TherapeuticsMD Inc's hormone therapy for a painful condition triggered by menopause, the women's health company said on Wednesday.

BRIEF-Therapeutics MD Reports Loss Per Share Of $0.11

* THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS

BRIEF-TherapeuticsMD Enters Into Negotiations With U.S. FDA For TX-004HR

* ENTERED INTO NEGOTIATIONS WITH U.S. FOOD AND DRUG ADMINISTRATION REGARDING PROPOSED LABEL FOR TX-004HR

Select another date: